Results 161 to 170 of about 494,545 (309)
Progress and challenge of hepatitis B virus mucosal vaccines. [PDF]
Renxuan J, Hongxiang L, Daru L.
europepmc +1 more source
2021 National viral hepatitis progress report [PDF]
The National Viral Hepatitis Progress Report provides information on ten data indicators, providing an objective way to assess progress toward achieving key viral hepatitis goals.Publication date from document properties.FactSheet ...
core
ABSTRACT The cardiovascular–kidney–metabolic (CKM) framework and metabolic dysfunction–associated steatotic liver disease (MASLD) describe a shared clinical continuum, but the prognostic value of joint fatty liver index (FLI)–NAFLD fibrosis score (NFS) phenotypes across CKM stages is uncertain.
Yi‐Fei Wang +5 more
wiley +1 more source
Emerging Serological Biomarkers for Autoimmune Hepatitis. [PDF]
Abe K, Wada J, Ohira H.
europepmc +1 more source
ABSTRACT Few prediction models have been specifically designed to evaluate the risk of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B and cirrhosis. This study aimed to develop a machine learning‐based prediction model to assess the risk of developing HCC in patients with hepatitis B virus (HBV)‐related cirrhosis undergoing nucleos(
Pao‐Yuan Huang +4 more
wiley +1 more source
Advancing Global Hepatitis B Elimination: The Case for Using Maize as a Low-Cost, Heat-Stable, and Scalable Oral Vaccine. [PDF]
Watanabe M, Howard JA.
europepmc +1 more source
ABSTRACT Serum‐based fibrosis scores are widely used for noninvasive risk stratification in chronic liver disease; however, direct comparisons across liver disease etiologies remain limited, particularly in Asian populations with a high prevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) infection.
Sheng‐Feng Lin, Chun‐Chao Chang
wiley +1 more source
Sequential Immune-Mediated Extrahepatic Complications of Hepatitis E Virus: A Case Report. [PDF]
Padarabinda Tripathy K +4 more
europepmc +1 more source
HLA ANTIGENS IN HBsAg POSITIVE CHRONIC HEPATITIS
Orhan ERBAŞ +5 more
doaj
Immune-Related Hepatotoxicity After Atezolizumab and Isoniazid. [PDF]
Karakaya E +5 more
europepmc +1 more source

